These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7296904

  • 1. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
    Sólyom J.
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
    [Abstract] [Full Text] [Related]

  • 2. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia.
    Robinson JA, Dyas J, Hughes IA, Riad-Fahmy D.
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():58-65. PubMed ID: 3827186
    [Abstract] [Full Text] [Related]

  • 3. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
    Riordan FA, Wood PJ, Wakelin K, Betts P, Clayton BE.
    Lancet; 1984 Mar 31; 1(8379):708-11. PubMed ID: 6143043
    [Abstract] [Full Text] [Related]

  • 4. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 5. "Dot-17 alpha-hydroxyprogesterone" radioimmunoassay for identification of congenital adrenal hyperplasia in young infants.
    Sólyom J, Hervei S, Marossy P, Sólyom E, Babosa M, Szombathy G.
    Acta Paediatr Scand; 1981 Nov 09; 70(6):913-7. PubMed ID: 7324946
    [Abstract] [Full Text] [Related]

  • 6. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
    Sólyom J, Hosszu E, Gács G.
    Exp Clin Endocrinol; 1990 Sep 09; 96(1):52-6. PubMed ID: 2279525
    [Abstract] [Full Text] [Related]

  • 7. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Sep 09; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 8. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
    Thompson R, Seargeant L, Winter JS.
    J Pediatr; 1989 Mar 09; 114(3):400-4. PubMed ID: 2784166
    [Abstract] [Full Text] [Related]

  • 9. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Shibata Y.
    Nihon Naibunpi Gakkai Zasshi; 1991 Aug 20; 67(8):819-39. PubMed ID: 1813324
    [Abstract] [Full Text] [Related]

  • 10. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
    Birkebaek NH, Hougaard DM, Cohen AS.
    J Pediatr Endocrinol Metab; 2017 Jan 01; 30(1):85-88. PubMed ID: 27977405
    [Abstract] [Full Text] [Related]

  • 11. Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiency.
    Shimon I, Kaiserman I, Sack J.
    Horm Res; 1995 Jan 01; 44(6):247-52. PubMed ID: 8808009
    [Abstract] [Full Text] [Related]

  • 12. Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroid profiles in congenital adrenal hyperplasia.
    Erhardt E, Sólyom J, Homoki J, Juricskay S, Soltész G.
    J Pediatr Endocrinol Metab; 2000 Feb 01; 13(2):205-10. PubMed ID: 10711668
    [Abstract] [Full Text] [Related]

  • 13. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ, Yong AB, Warne GL, Montalto J.
    J Paediatr Child Health; 1995 Feb 01; 31(1):47-50. PubMed ID: 7748691
    [Abstract] [Full Text] [Related]

  • 14. Serum 17 alpha-hydroxyprogesterone in infants and children as measured by a direct radioimmunoassay kit.
    Lee A, Ellis G.
    Clin Biochem; 1991 Dec 01; 24(6):505-11. PubMed ID: 1773491
    [Abstract] [Full Text] [Related]

  • 15. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
    Hubl W, Fehér T, Rohde W, Dörner G, Taubert H, Freymann E.
    Endokrinologie; 1982 Jun 01; 79(2):165-72. PubMed ID: 6751805
    [Abstract] [Full Text] [Related]

  • 16. Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.
    Atherden SM, Barnes ND, Grant DB.
    Arch Dis Child; 1972 Aug 01; 47(254):602-4. PubMed ID: 5046776
    [Abstract] [Full Text] [Related]

  • 17. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
    von Schnakenburg K, Bidlingmaier F, Knorr D.
    Eur J Pediatr; 1980 May 01; 133(3):259-67. PubMed ID: 7389739
    [Abstract] [Full Text] [Related]

  • 18. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
    J Clin Endocrinol Metab; 1983 Dec 01; 57(6):1150-4. PubMed ID: 6605355
    [Abstract] [Full Text] [Related]

  • 19. Age of appearance of circadian rhythm in blood 17-hydroxyprogesterone in 21-hydroxylase deficiency.
    Sólyom J.
    Acta Physiol Hung; 1991 Dec 01; 78(2):107-10. PubMed ID: 1808976
    [Abstract] [Full Text] [Related]

  • 20. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone].
    Shimozawa K.
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec 20; 59(12):1845-9. PubMed ID: 6609091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.